Valuation Update With 7 Day Price Move • Jun 09
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to JP¥206, the stock trades at a trailing P/E ratio of 42.2x. Average trailing P/E is 24x in the Life Sciences industry in Japan. Total loss to shareholders of 41% over the past three years. Tillkännagivande • Jun 03
Precision System Science Co., Ltd. to Report Fiscal Year 2026 Results on Aug 14, 2026 Precision System Science Co., Ltd. announced that they will report fiscal year 2026 results on Aug 14, 2026 Reported Earnings • May 20
Third quarter 2026 earnings released: EPS: JP¥5.10 (vs JP¥1.09 loss in 3Q 2025) Third quarter 2026 results: EPS: JP¥5.10 (up from JP¥1.09 loss in 3Q 2025). Revenue: JP¥1.24b (down 1.7% from 3Q 2025). Net income: JP¥140.0m (up JP¥170.0m from 3Q 2025). Profit margin: 11% (up from net loss in 3Q 2025). Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Reported Earnings • Feb 18
Second quarter 2026 earnings released: EPS: JP¥0.26 (vs JP¥2.79 loss in 2Q 2025) Second quarter 2026 results: EPS: JP¥0.26 (up from JP¥2.79 loss in 2Q 2025). Revenue: JP¥1.22b (up 8.8% from 2Q 2025). Net income: JP¥7.00m (up JP¥84.0m from 2Q 2025). Profit margin: 0.6% (up from net loss in 2Q 2025). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings. New Risk • Feb 02
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 47% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (5.3% average weekly change). Market cap is less than US$100m (JP¥6.17b market cap, or US$39.9m). Tillkännagivande • Dec 03
Precision System Science Co., Ltd. to Report Q3, 2026 Results on May 15, 2026 Precision System Science Co., Ltd. announced that they will report Q3, 2026 results on May 15, 2026 Tillkännagivande • Dec 02
Precision System Science Co., Ltd. to Report Q2, 2026 Results on Feb 16, 2026 Precision System Science Co., Ltd. announced that they will report Q2, 2026 results on Feb 16, 2026 Tillkännagivande • Oct 17
Precision System Science Co., Ltd. to Report Q1, 2026 Results on Nov 14, 2025 Precision System Science Co., Ltd. announced that they will report Q1, 2026 results on Nov 14, 2025 Reported Earnings • Oct 04
Full year 2025 earnings released: JP¥9.20 loss per share (vs JP¥40.57 loss in FY 2024) Full year 2025 results: JP¥9.20 loss per share (improved from JP¥40.57 loss in FY 2024). Revenue: JP¥4.69b (up 18% from FY 2024). Net loss: JP¥253.0m (loss narrowed 77% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has fallen by 25% per year, which means it is performing significantly worse than earnings. Reported Earnings • Aug 16
Full year 2025 earnings released: JP¥9.20 loss per share (vs JP¥40.57 loss in FY 2024) Full year 2025 results: JP¥9.20 loss per share (improved from JP¥40.57 loss in FY 2024). Revenue: JP¥4.69b (up 18% from FY 2024). Net loss: JP¥253.0m (loss narrowed 77% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has fallen by 27% per year, which means it is performing significantly worse than earnings. Tillkännagivande • Aug 14
Precision System Science Co., Ltd., Annual General Meeting, Sep 26, 2025 Precision System Science Co., Ltd., Annual General Meeting, Sep 26, 2025. Tillkännagivande • Jun 29
Precision System Science Co., Ltd. to Report Fiscal Year 2025 Results on Aug 14, 2025 Precision System Science Co., Ltd. announced that they will report fiscal year 2025 results on Aug 14, 2025 Reported Earnings • May 21
Third quarter 2025 earnings released: JP¥1.09 loss per share (vs JP¥2.53 profit in 3Q 2024) Third quarter 2025 results: JP¥1.09 loss per share (down from JP¥2.53 profit in 3Q 2024). Revenue: JP¥1.27b (up 36% from 3Q 2024). Net loss: JP¥30.0m (down 143% from profit in 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings. Tillkännagivande • Mar 07
Precision System Science Co., Ltd. (TSE:7707) announces an Equity Buyback for 440,600 shares, for ¥100.46 million. Precision System Science Co., Ltd. (TSE:7707) announces a share repurchase program. Under the program, the company will repurchase up to 440,600 shares of its issued shares for a total of ¥100.46 million. The shares will be repurchased at a purchase price of ¥228 per share. The purpose of the program is to enhance shareholder returns and improve capital efficiency. Tillkännagivande • Mar 01
Precision System Science Co., Ltd. to Report Q3, 2025 Results on May 15, 2025 Precision System Science Co., Ltd. announced that they will report Q3, 2025 results on May 15, 2025 Reported Earnings • Feb 16
Second quarter 2025 earnings released: JP¥2.79 loss per share (vs JP¥18.46 loss in 2Q 2024) Second quarter 2025 results: JP¥2.79 loss per share (improved from JP¥18.46 loss in 2Q 2024). Revenue: JP¥1.12b (up 19% from 2Q 2024). Net loss: JP¥77.0m (loss narrowed 85% from 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 48 percentage points per year, which is a significant difference in performance. Tillkännagivande • Dec 14
Precision System Science Co., Ltd. to Report Q2, 2025 Results on Feb 14, 2025 Precision System Science Co., Ltd. announced that they will report Q2, 2025 results on Feb 14, 2025 Reported Earnings • Oct 03
Full year 2024 earnings released: JP¥40.57 loss per share (vs JP¥47.92 loss in FY 2023) Full year 2024 results: JP¥40.57 loss per share (improved from JP¥47.92 loss in FY 2023). Revenue: JP¥3.98b (down 25% from FY 2023). Net loss: JP¥1.12b (loss narrowed 15% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 80 percentage points per year, which is a significant difference in performance. Tillkännagivande • Sep 04
Precision System Science Co., Ltd. to Report Q1, 2025 Results on Nov 14, 2024 Precision System Science Co., Ltd. announced that they will report Q1, 2025 results on Nov 14, 2024 Reported Earnings • Aug 19
Full year 2024 earnings released: JP¥40.57 loss per share (vs JP¥47.92 loss in FY 2023) Full year 2024 results: JP¥40.57 loss per share (improved from JP¥47.92 loss in FY 2023). Revenue: JP¥3.98b (down 25% from FY 2023). Net loss: JP¥1.12b (loss narrowed 15% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance. Tillkännagivande • Aug 15
Tajima agreed to acquire Universal Bio Research Co., Ltd from Precision System Science Co., Ltd. (TSE:7707) for ¥60 million. Shuji Tajima agreed to acquire Universal Bio Research Co., Ltd from Precision System Science Co., Ltd. (TSE:7707) for ¥60 million on August 14, 2024. A cash consideration of ¥60 million will be paid by the buyer. As part of consideration, ¥60 million is paid towards common equity of Universal Bio Research Co., Ltd.
For the period ending June 30, 2024, Universal Bio Research Co., Ltd reported total revenue of ¥60.41 million, EBIT of ¥17.4 million and net income of ¥17.17 million. As of June 30, 2024, Universal Bio Research Co., Ltd reported total assets of ¥137.53 million and total common equity of ¥132.54 million.
The expected completion of the transaction is December 31, 2024. Tillkännagivande • Aug 14
Precision System Science Co., Ltd., Annual General Meeting, Sep 27, 2024 Precision System Science Co., Ltd., Annual General Meeting, Sep 27, 2024. New Risk • Jul 18
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 7.6% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.6% average weekly change). Earnings have declined by 55% per year over the past 5 years. Minor Risk Market cap is less than US$100m (JP¥6.77b market cap, or US$43.3m). Reported Earnings • May 21
Third quarter 2024 earnings released: EPS: JP¥2.53 (vs JP¥6.51 loss in 3Q 2023) Third quarter 2024 results: EPS: JP¥2.53 (up from JP¥6.51 loss in 3Q 2023). Revenue: JP¥929.0m (down 14% from 3Q 2023). Net income: JP¥70.0m (up JP¥250.0m from 3Q 2023). Profit margin: 7.5% (up from net loss in 3Q 2023). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 74 percentage points per year, which is a significant difference in performance. Tillkännagivande • Mar 02
Precision System Science Co., Ltd. to Report Q3, 2024 Results on May 15, 2024 Precision System Science Co., Ltd. announced that they will report Q3, 2024 results on May 15, 2024 Reported Earnings • Feb 18
Second quarter 2024 earnings released: JP¥18.46 loss per share (vs JP¥6.44 loss in 2Q 2023) Second quarter 2024 results: JP¥18.46 loss per share (further deteriorated from JP¥6.44 loss in 2Q 2023). Revenue: JP¥940.0m (down 41% from 2Q 2023). Net loss: JP¥510.0m (loss widened 187% from 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance. New Risk • Feb 16
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 30% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (5.6% average weekly change). Market cap is less than US$100m (JP¥5.28b market cap, or US$35.2m). Tillkännagivande • Dec 08
Precision System Science Co., Ltd. to Report Q2, 2024 Results on Feb 13, 2024 Precision System Science Co., Ltd. announced that they will report Q2, 2024 results on Feb 13, 2024 Reported Earnings • Nov 18
First quarter 2024 earnings released: JP¥7.85 loss per share (vs JP¥10.42 loss in 1Q 2023) First quarter 2024 results: JP¥7.85 loss per share (improved from JP¥10.42 loss in 1Q 2023). Revenue: JP¥1.07b (down 30% from 1Q 2023). Net loss: JP¥217.0m (loss narrowed 25% from 1Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 68 percentage points per year, which is a significant difference in performance. Tillkännagivande • Sep 24
Precision System Science Co., Ltd. to Report Q1, 2024 Results on Nov 14, 2023 Precision System Science Co., Ltd. announced that they will report Q1, 2024 results on Nov 14, 2023 New Risk • Aug 16
New major risk - Revenue and earnings growth Earnings have declined by 9.3% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 9.3% per year over the past 5 years. Minor Risk Market cap is less than US$100m (JP¥8.92b market cap, or US$61.4m). Reported Earnings • Aug 16
Full year 2023 earnings released: JP¥47.92 loss per share (vs JP¥1.63 profit in FY 2022) Full year 2023 results: JP¥47.92 loss per share (down from JP¥1.63 profit in FY 2022). Revenue: JP¥5.28b (down 29% from FY 2022). Net loss: JP¥1.32b (down JP¥1.37b from profit in FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 39 percentage points per year, which is a significant difference in performance. Reported Earnings • May 19
Third quarter 2023 earnings released: JP¥6.51 loss per share (vs JP¥2.86 loss in 3Q 2022) Third quarter 2023 results: JP¥6.51 loss per share (further deteriorated from JP¥2.86 loss in 3Q 2022). Revenue: JP¥1.08b (down 42% from 3Q 2022). Net loss: JP¥180.0m (loss widened 128% from 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 33% per year, which means it has not declined as severely as earnings. Reported Earnings • Feb 15
Second quarter 2023 earnings released: JP¥6.44 loss per share (vs JP¥0.80 loss in 2Q 2022) Second quarter 2023 results: JP¥6.44 loss per share (further deteriorated from JP¥0.80 loss in 2Q 2022). Revenue: JP¥1.60b (down 7.2% from 2Q 2022). Net loss: JP¥178.0m (loss widened JP¥156.0m from 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings. Tillkännagivande • Feb 10
Precision System Science Co., Ltd. to Report Q2, 2023 Results on Feb 14, 2023 Precision System Science Co., Ltd. announced that they will report Q2, 2023 results on Feb 14, 2023 Reported Earnings • Nov 16
First quarter 2023 earnings released: JP¥10.42 loss per share (vs JP¥3.61 profit in 1Q 2022) First quarter 2023 results: JP¥10.42 loss per share (down from JP¥3.61 profit in 1Q 2022). Revenue: JP¥1.53b (down 18% from 1Q 2022). Net loss: JP¥288.0m (down 388% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Daisuke Ogiwara was the last director to join the board, commencing their role in 2020. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 13
First quarter 2023 earnings released: JP¥10.42 loss per share (vs JP¥3.61 profit in 1Q 2022) First quarter 2023 results: JP¥10.42 loss per share (down from JP¥3.61 profit in 1Q 2022). Revenue: JP¥1.53b (down 18% from 1Q 2022). Net loss: JP¥288.0m (down 388% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth. Reported Earnings • Oct 06
Full year 2022 earnings: EPS and revenues miss analyst expectations Full year 2022 results: EPS: JP¥1.63 (down from JP¥29.21 in FY 2021). Revenue: JP¥7.43b (down 20% from FY 2021). Net income: JP¥45.0m (down 94% from FY 2021). Profit margin: 0.6% (down from 8.6% in FY 2021). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 7.1%. Earnings per share (EPS) also missed analyst estimates by 89%. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth. Tillkännagivande • Sep 28
Precision System Science Co., Ltd. to Report Q1, 2023 Results on Nov 11, 2022 Precision System Science Co., Ltd. announced that they will report Q1, 2023 results on Nov 11, 2022 Tillkännagivande • Aug 14
Precision System Science Co., Ltd., Annual General Meeting, Sep 28, 2022 Precision System Science Co., Ltd., Annual General Meeting, Sep 28, 2022. Reported Earnings • Aug 14
Full year 2022 earnings: EPS and revenues miss analyst expectations Full year 2022 results: EPS: JP¥1.63 (down from JP¥29.21 in FY 2021). Revenue: JP¥7.43b (down 20% from FY 2021). Net income: JP¥45.0m (down 94% from FY 2021). Profit margin: 0.6% (down from 8.6% in FY 2021). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 7.1%. Earnings per share (EPS) also missed analyst estimates by 89%. Over the next year, revenue is forecast to grow 12%, compared to a 16% growth forecast for the pharmaceuticals industry in Japan. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Aug 01
Investor sentiment deteriorated over the past week After last week's 19% share price decline to JP¥674, the stock trades at a forward P/E ratio of 43x. Average forward P/E is 19x in the Life Sciences industry in Japan. Total returns to shareholders of 70% over the past three years. Buying Opportunity • Jul 27
Now 21% undervalued Over the last 90 days, the stock is up 63%. The fair value is estimated to be JP¥878, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 29% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 12% in 2 years. Earnings is forecast to grow by 92% in the next 2 years. Valuation Update With 7 Day Price Move • Jul 09
Investor sentiment improved over the past week After last week's 23% share price gain to JP¥575, the stock trades at a forward P/E ratio of 36x. Average forward P/E is 17x in the Life Sciences industry in Japan. Total returns to shareholders of 41% over the past three years. Valuation Update With 7 Day Price Move • Jun 24
Investor sentiment improved over the past week After last week's 28% share price gain to JP¥463, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 17x in the Life Sciences industry in Japan. Total returns to shareholders of 9.1% over the past three years. Tillkännagivande • Jun 03
Precision System Science Co., Ltd. to Report Fiscal Year 2022 Results on Aug 12, 2022 Precision System Science Co., Ltd. announced that they will report fiscal year 2022 results on Aug 12, 2022 Reported Earnings • May 17
Third quarter 2022 earnings: EPS and revenues exceed analyst expectations Third quarter 2022 results: JP¥2.86 loss per share (down from JP¥3.87 profit in 3Q 2021). Revenue: JP¥1.87b (down 20% from 3Q 2021). Net loss: JP¥79.0m (down 174% from profit in 3Q 2021). Revenue exceeded analyst estimates by 3.3%. Earnings per share (EPS) missed analyst estimates. Over the next year, revenue is forecast to grow 4.2% compared to a 4.4% decline forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Board Change • Apr 27
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Daisuke Ogiwara was the last director to join the board, commencing their role in 2020. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Buying Opportunity • Apr 07
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 3.8%. The fair value is estimated to be JP¥572, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 33% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 3.4% in 2 years. Earnings is forecast to grow by 11% in the next 2 years. Price Target Changed • Mar 16
Price target decreased to JP¥480 Down from JP¥730, the current price target is provided by 1 analyst. New target price is 22% above last closing price of JP¥392. Stock is down 57% over the past year. The company is forecast to post earnings per share of JP¥14.50 for next year compared to JP¥29.21 last year. Tillkännagivande • Feb 27
Precision System Science Co., Ltd. to Report Q3, 2022 Results on May 13, 2022 Precision System Science Co., Ltd. announced that they will report Q3, 2022 results on May 13, 2022 Reported Earnings • Feb 16
Second quarter 2022 earnings: EPS and revenues exceed analyst expectations Second quarter 2022 results: JP¥0.80 loss per share (down from JP¥5.85 profit in 2Q 2021). Revenue: JP¥1.72b (down 30% from 2Q 2021). Net loss: JP¥22.0m (down 114% from profit in 2Q 2021). Revenue exceeded analyst estimates by 3.3%. Earnings per share (EPS) missed analyst estimates. Over the next year, revenue is forecast to grow 7.6% compared to a 1.9% decline forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 102% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Feb 16
Investor sentiment deteriorated over the past week After last week's 15% share price decline to JP¥425, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 41x in the Life Sciences industry in Asia. Total returns to shareholders of 18% over the past three years. Valuation Update With 7 Day Price Move • Jan 28
Investor sentiment improved over the past week After last week's 29% share price gain to JP¥575, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 41x in the Life Sciences industry in Asia. Total returns to shareholders of 92% over the past three years. Reported Earnings • Nov 15
First quarter 2022 earnings released: EPS JP¥3.61 (vs JP¥7.43 in 1Q 2021) The company reported a poor first quarter result with weaker earnings, revenues and profit margins. First quarter 2022 results: Revenue: JP¥1.87b (down 9.9% from 1Q 2021). Net income: JP¥100.0m (down 49% from 1Q 2021). Profit margin: 5.3% (down from 9.4% in 1Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 116% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth. Reported Earnings • Oct 05
Full year 2021 earnings released: EPS JP¥29.21 (vs JP¥4.40 loss in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: JP¥9.30b (up 84% from FY 2020). Net income: JP¥795.0m (up JP¥909.0m from FY 2020). Profit margin: 8.6% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 123% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Aug 19
Investor sentiment deteriorated over the past week After last week's 17% share price decline to JP¥670, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 61x in the Life Sciences industry in Asia. Total returns to shareholders of 53% over the past three years. Tillkännagivande • Aug 14
Precision System Science Co., Ltd. (TSE:7707) announces an Equity Buyback for 200,000 shares, representing 0.72% for ¥100 million. Precision System Science Co., Ltd. (TSE:7707) announces a share repurchase program. Under the program, the company will repurchase up to 200,000 shares, representing 0.72% of its issued share capital (excluding treasury stock), at ¥500 per share, for ¥100 million. The purpose of the program is to enhance shareholder returns and to increase the agility of capital policies, and providing incentives for the sustainable improvement of the company's corporate value. The program will run until October 29, 2021. As of June 30, 2021, the company had 27,666,900 shares in issue (excluding treasury stock) and 86 shares in treasury. Reported Earnings • May 17
Third quarter 2021 earnings released: EPS JP¥3.87 (vs JP¥0.42 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: JP¥2.34b (up 74% from 3Q 2020). Net income: JP¥107.0m (up JP¥96.0m from 3Q 2020). Profit margin: 4.6% (up from 0.8% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 120% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Feb 19
Investor sentiment deteriorated over the past week After last week's 26% share price decline to JP¥888, the stock is trading at a trailing P/E ratio of 52.8x, down from the previous P/E ratio of 71.7x. This compares to an average P/E of 41x in the Life Sciences industry in Japan. Total returns to shareholders over the past three years are 51%. Is New 90 Day High Low • Feb 18
New 90-day low: JP¥888 The company is down 30% from its price of JP¥1,270 on 20 November 2020. The Japanese market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Life Sciences industry, which is up 4.0% over the same period. Reported Earnings • Feb 14
Second quarter 2021 earnings released: EPS JP¥5.85 (vs JP¥3.63 loss in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: JP¥2.45b (up 121% from 2Q 2020). Net income: JP¥159.0m (up JP¥253.0m from 2Q 2020). Profit margin: 6.5% (up from net loss in 2Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 112% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth. Tillkännagivande • Jan 03
Precision System Science Co., Ltd. to Report Q2, 2021 Results on Feb 12, 2021 Precision System Science Co., Ltd. announced that they will report Q2, 2021 results on Feb 12, 2021 Is New 90 Day High Low • Dec 22
New 90-day low: JP¥948 The company is down 36% from its price of JP¥1,473 on 23 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Life Sciences industry, which is down 18% over the same period. Is New 90 Day High Low • Dec 07
New 90-day low: JP¥1,050 The company is down 33% from its price of JP¥1,571 on 08 September 2020. The Japanese market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Life Sciences industry, which is down 8.0% over the same period. Price Target Changed • Dec 01
Price target raised to JP¥660 Up from JP¥400, the current price target is provided by 1 analyst. The new target price is 43% below the current share price of JP¥1,168. As of last close, the stock is up 199% over the past year. Tillkännagivande • Oct 10
Precision System Science Co., Ltd. to Report Q1, 2021 Results on Nov 13, 2020 Precision System Science Co., Ltd. announced that they will report Q1, 2021 results on Nov 13, 2020